Texas Center for Proton Therapy

If you don’t smoke, you’ve eliminated one of the biggest risk factors for developing lung cancer. But in the United States, about 10 to 20% of lung cancer diagnoses happen in people who have never smoked or have smoked fewer than 100 cigarettes in their lifetime. If any of the following factors apply to you, talk to your doctor about a screening for lung cancer.

We had a great afternoon kicking off the holiday season with a potluck! Our team brought an incredible array of dishes, from savory mains to delectable desserts. We are thankful for our amazing staff and everything they do to provide high-quality care to our patients.

While caregivers play a key role in managing a patient’s physical and emotional well-being, it’s important to practice self-care to avoid caregiver fatigue and burnout. Remember to take time for yourself and build a support network – connect with family, friends, or a support group and don’t hesitate to ask for help. Here are some helpful tips for providing support to you and your loved ones.

On Veterans Day, we would like to recognize and honor the men and women who have served our country and give a special thank you to our veterans on staff at Texas Center for Proton Therapy. Thank you for your service!

It’s National Radiologic Technology Week? and we want to take a moment to express our deepest gratitude to our incredible radiation therapists and imaging staff. Your dedication, compassion, and expertise continue to make a profound difference in the lives of our patients.

Lung cancer is the second most common cancer in both men and women in the United States. The American Cancer Society estimates that there will be about 234,580 new cases of lung cancer in 2024. Learn the signs and symptoms and read more about proton therapy for lung cancer here: https://lnkd.in/ghkgz8k3

?? ?? Wrapping up Breast Cancer Awareness Month with an essential update on long-term heart health for breast cancer survivors. A new study in the American Society of Clinical Oncology (ASCO) Journal of Clinical Oncology reveals that cardiac dysfunction among survivors increased eightfold over 13 years, particularly impacting those treated with conventional radiation. Proton therapy experts at Texas Center for Proton Therapy contributed insights to this NAPT Research Update, highlighting proton therapy’s potential to reduce radiation exposure to the heart and lungs, helping lower long-term risks for cardiovascular issues. With this groundbreaking data, patients and providers have more tools to choose treatments that prioritize both survival and quality of life. Visit the NAPT website to read the full research update and explore the latest in proton therapy advancements. #BreastCancerAwareness #ProtonTherapy #HeartHealth https://lnkd.in/g-prwXF9

While you can’t inherit cancer, you can inherit a higher risk for developing it. ?Genetic testing can help determine if you have an increased risk for certain?types of cancer, including breast, ovarian, colorectal, and uterine cancer. Genetic testing provides early detection, reduces cancer risk, and saves lives. Talk to your doctor annually to see what tests are right for you.

A study published in the American Society of Clinical Oncology (ASCO) reports that incidences of cardiac dysfunction amongst breast cancer survivors increased eightfold within the span of 13 years. The study involved patients who had completed cardiotoxic therapy and underwent echocardiographic screening every two years. These findings provide evidence for surveillance post treatment for several years after cardiotoxic therapy, as well as the need to examine and reevaluate the efficacy of radiation treatment options offered to breast cancer patients, bearing long-term health outcomes in mind. Read the key findings here: https://lnkd.in/guDyH_fw

While breast cancer is primarily diagnosed in women, it can develop in both men and women at any time. Proton therapy provides a potential solution for minimizing cardiac exposure, particularly in people with left-sided breast cancer. Minimizing cardiac toxicity is critical, as increased heart dose in breast radiotherapy is associated with an increased risk of major cardiovascular events.